Effects of terpenes in the treatment of visceral leishmaniasis: A systematic review of preclinical evidence
Visceral leishmaniasis (VL) is a severe and potentially fatal neglected tropical disease, being considered a public health concern in many countries worldwide. There are still no vaccines against human VL, and the existing chemotherapy is often toxic. Thereby, alternative treatments have been invest...
Saved in:
Main Authors: | Vagner Dias Raimundo (Author), Renner Philipe Rodrigues Carvalho (Author), Mariana Machado-Neves (Author), Eduardo de Almeida Marques- (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence for visceral leishmaniasis elimination in Nepal
by: Megha Raj Banjara, et al.
Published: (2020) -
Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2021) -
Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis
by: Andressa Barros Ibiapina, et al.
Published: (2022) -
Terpenes and Terpenoids
Published: (2018) -
SPECIALIZED NURSING TERMINOLOGY FOR PEOPLE WITH VISCERAL LEISHMANIASIS
by: Diego Dias de Araújo, et al.
Published: (2023)